Optiver Holding B.V. Morpho Sys Ag Transaction History

Optiver Holding B.V.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$4.55 - $9.9 $89,325 - $194,356	-19,632 Reduced 13.63%	124,410 $1.23 Million
Q3 2023 Nov 13, 2023	BUY	$6.72 - $8.6 $956,807 - $1.22 Million	142,382 Added 8577.23%	144,042 $967,000
Q2 2023 Aug 10, 2023	SELL	$3.95 - $7.74 $475,216 - $931,183	-120,308 Reduced 98.64%	1,660 $12,000
Q1 2023 May 11, 2023	BUY	$3.56 - $5.22 $212,026 - $310,892	59,558 Added 95.43%	121,968 $482,000
Q4 2022 Feb 10, 2023	BUY	$3.21 - $5.74 $149,338 - $267,042	46,523 Added 292.84%	62,410 $223,000
Q3 2022 Nov 14, 2022	SELL	$4.14 - $22.13 $225,315 - $1.2 Million	-54,424 Reduced 77.4%	15,887 $80,000
Q2 2022 Aug 10, 2022	BUY	$4.51 - $7.39 $317,102 - $519,598	70,311 New	70,311 $340,000
Q1 2022 May 16, 2022	SELL	$5.87 - $9.73 $186,002 - $308,314	-31,687 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.08 - $12.45 $241,319 - $330,883	26,577 Added 520.1%	31,687 $298,000
Q3 2021 Nov 15, 2021	SELL	$11.76 - $19.51 $258,461 - $428,790	-21,978 Reduced 81.14%	5,110 $60,000
Q2 2021 Aug 16, 2021	SELL	$18.95 - $23.95 $914,545 - $1.16 Million	-48,261 Reduced 64.05%	27,088 $521,000
Q1 2021 May 14, 2021	BUY	$21.56 - $30.66 $1.62 Million - $2.31 Million	75,349 New	75,349 $3.06 Million

1.8M

14.7K

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.